Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Marzo

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Science (New York, N.Y.)|March 27, 2001
Preferential localization of effector memory cells in nonlymphoid tissueD Masopust, V Vezys, A L Marzo, et al.
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Pillars article: preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001. 291: 2413-2417David Masopust, Vaiva Vezys, Amanda L Marzo, et al.
Sangre|January 1, 1977
[A deletion D--/D-- with antibodies causing a severe haemolytic disease of the newborn (author's transl)]C Buñuel, E Aztarain, L Marzo, et al.
Sangre|June 1, 1990
[Incidence of anti-HCV and ALT in blood donors]Y Martín, L Marzo, F Cinto, et al.
Plos One|August 23, 2012
Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumorsNadine M Lerret, Magdalena Rogozinska, Andrés Jaramillo, et al.
Sangre|January 1, 1976
[Quantitative assay of some red-cell antigens in the refractory anaemias (author's transl)]L Marzo, J M Lapeña, E Aztarain, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
Sangre|August 1, 1990
[Autoimmune hemolytic anemia in a myelodysplastic syndrome]L Perdiguer, J Bergua, L Marzo, et al.
Cancer Research|August 1, 1997
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivoA L Marzo, D R Fitzpatrick, B W Robinson, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|March 27, 2001
Preferential localization of effector memory cells in nonlymphoid tissueD Masopust, V Vezys, A L Marzo, et al.
European Journal of Immunology|March 3, 2007
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cellsVictoria A Graham, Amanda L Marzo, David F Tough
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Pillars article: preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001. 291: 2413-2417David Masopust, Vaiva Vezys, Amanda L Marzo, et al.
Sangre|January 1, 1977
[A deletion D--/D-- with antibodies causing a severe haemolytic disease of the newborn (author's transl)]C Buñuel, E Aztarain, L Marzo, et al.
Sangre|June 1, 1990
[Incidence of anti-HCV and ALT in blood donors]Y Martín, L Marzo, F Cinto, et al.
Plos One|August 23, 2012
Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumorsNadine M Lerret, Magdalena Rogozinska, Andrés Jaramillo, et al.
Sangre|January 1, 1976
[Quantitative assay of some red-cell antigens in the refractory anaemias (author's transl)]L Marzo, J M Lapeña, E Aztarain, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
Sangre|August 1, 1990
[Autoimmune hemolytic anemia in a myelodysplastic syndrome]L Perdiguer, J Bergua, L Marzo, et al.
Cancer Research|August 1, 1997
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivoA L Marzo, D R Fitzpatrick, B W Robinson, et al.
Pageof 6